Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for icosapent root_names_stdName in Standardized Name (approximate match)

Showing 481 - 490 of 12523 results

First page
Previous page
Next page
Next page

Udifitimod

283FTA936D

Search for Structure

Status:

Investigational

Source:

NCT03038711: Phase 1 Interventional Completed Ulcerative Colitis

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03038711

Class (Stereo):

CHEMICAL (ABSOLUTE)

MODIPAFANT, (±)-

3QK4U86953

Search for Structure

Status:

Investigational

Source:

INN:modipafant

Source URL:

https://tripod.nih.gov/npc/#Download

Class (Stereo):

CHEMICAL (RACEMIC)

CHIGLITAZAR

E6EJV1J6Y0

Search for Structure

Status:

Investigational

Source:

NCT02173457: Phase 3 Interventional Completed Type 2 Diabetes

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02173457

Class (Stereo):

CHEMICAL (ABSOLUTE)

PIMITESPIB

PLO044MUDZ

Search for Structure

Status:

Investigational

Source:

NCT02965885: Phase 1 Interventional Completed Advanced Solid Tumors

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02965885

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Heat shock protein HSP 90-alpha

Heat shock protein HSP 90-beta

Conditions:

Gastrointestinal stromal tumor

TAS-116 is a highly potent oral HSP90 inhibitor with unique tissue distribution properties. TAS-116 has the potential to demonstrate antitumor activity, while being designed to limit certain adverse events by unique tissue distribution. Phase-II clinical trials in gastrointestinal stromal tumours are ongoing in Japan.

PF-05105679

F2B10OFV7Y

Search for Structure

Status:

Investigational

Source:

NCT01393652: Phase 1 Interventional Completed Healthy Volunteers

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01393652

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Transient receptor potential cation channel subfamily M member 8

Vilagletistat

T4SR539YKF

Search for Structure

Status:

Investigational

Source:

INN:vilagletistat [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/T4SR539YKF

Class (Stereo):

CHEMICAL (ABSOLUTE)

CREATINE ETHYL ESTER

I3P1L0D47K

Search for Structure

Status:

Investigational

Source:

NCT01367717: Not Applicable Interventional Completed Acute Kidney Injury

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01367717

Class (Stereo):

CHEMICAL (ACHIRAL)

Zelatriazin

EXC8D658WN

Search for Structure

Status:

Investigational

Source:

INN:zelatriazin [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/EXC8D658WN

Class (Stereo):

CHEMICAL (ABSOLUTE)

DPOC-4088

S6MPG81Y84

Search for Structure

Status:

Investigational

Source:

NCT01347203: Phase 1 Interventional Completed Deep Vein Thrombosis Leg

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01347203

Class (Stereo):

CHEMICAL (ACHIRAL)

ASALIN

N7ISD24NIS

Search for Structure

Status:

Investigational

Source:

NCT01106846: Not Applicable Interventional Terminated Pain

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01106846

Class (Stereo):

CHEMICAL (MIXED)

Structure of Udifitimod

ABSOLUTE

Structure of MODIPAFANT, (±)-

RACEMIC

MODIPAFANT, (±)-

Structure of CHIGLITAZAR

ABSOLUTE

Structure of PIMITESPIB

ACHIRAL

Structure of PF-05105679

ABSOLUTE

Structure of Vilagletistat

ABSOLUTE

Structure of CREATINE ETHYL ESTER

ACHIRAL

CREATINE ETHYL ESTER

Structure of Zelatriazin

ABSOLUTE

Structure of DPOC-4088

ACHIRAL

Structure of ASALIN

MIXED

Showing 481 - 490 of 12523 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1